Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 12 November 2009, Vol. 114, No. 20, pp. 4422-4431.
Prepublished online as a Blood First Edition Paper on September 17, 2009; DOI 10.1182/blood-2009-06-227256.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2009-06-227256v1
114/20/4422    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Gruenbacher, G.
Right arrow Articles by Thurnher, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gruenbacher, G.
Right arrow Articles by Thurnher, M.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

CD56+ human blood dendritic cells effectively promote TH1-type {gamma}{delta} T-cell responses

Georg Gruenbacher1,2, Hubert Gander1,2, Andrea Rahm1,2, Walter Nussbaumer3, Nikolaus Romani1,2, and Martin Thurnher1,2

1 Cell Therapy Unit, Departments of Urology and Dermatology and Venereology, Innsbruck Medical University, Innsbruck; 2 K1 Center Oncotyrol, Innsbruck; and 3 Central Institute for Blood Transfusion, Innsbruck, Austria

CD56+ human dendritic cells (DCs) have recently been shown to differentiate from monocytes in response to GM-CSF and type 1 interferon in vitro. We show here that CD56+ cells freshly isolated from human peripheral blood contain a substantial subset of CD14+CD86+HLA-DR+ cells, which have the appearance of intermediate-sized lymphocytes but spontaneously differentiate into enlarged DC-like cells with substantially increased HLA-DR and CD86 expression or into fully mature CD83+ DCs in response to appropriate cytokines. Stimulation of CD56+ cells containing both DCs and abundant {gamma}{delta} T cells with zoledronate and interleukin-2 (IL-2) resulted in the rapid expansion of {gamma}{delta} T cells as well as in IFN-{gamma}, TNF-{alpha}, and IL-1β but not in IL-4, IL-10, or IL-17 production. IFN-{gamma}, TNF-{alpha}, and IL-1β production were almost completely abolished by depleting CD14+ cells from the CD56+ subset before stimulation. Likewise, depletion of CD14+ cells dramatically impaired {gamma}{delta} T-cell expansion. IFN-{gamma} production could also be blocked by neutralizing the effects of endogenous IL-1β and TNF-{alpha}. Conversely, addition of recombinant IL-1β, TNF-{alpha}, or both further enhanced IFN-{gamma} production and strongly up-regulated IL-6 production. Our data indicate that CD56+ DCs from human blood are capable of stimulating CD56+ {gamma}{delta} T cells, which may be harnessed for immunotherapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020